Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i36.6549 World J Gastroenterol 2017 September 28; 23(36): 6549-6570 ISSN 1007-9327 (print) ISSN 2219-2840 (online) REVIEW Treatment options for alcoholic and non-alcoholic fatty liver disease: A ...
Examined relationships between the Multidimensional Health Locus of Control (MHLC) Scales and subscales of the MMPI with inpatients (N = 90) at a Veterans Administration Medical Center Alcohol Dependency Treatment Unit. Comparison of MHLC scores for the alcoholic group and a normative sample of...
Aims: To examine the predictors and correlates of depression in alcoholic patients following detoxification and during outpatient treatment, and the role o... Lejoyeux,Michel,Lehert,... - 《Alcohol & Alcoholism》 被引量: 37发表: 2011年 A Comparison of Clonidine and Buprenorphine in the Outpatie...
Aim: Cisplatin doublets are standard 1st line treatment for advanced non-small cell lung cancer (NSCLC), without accurate predictor for response and surviv... Thierry,Berghmans,Lieveke,... - 《Frontiers in Oncology》 被引量: 11发表: 2015年 Comparison of progression between diabetic patients with...
Fn14, the receptor for TNF-like weak inducer of apoptosis, was selectively upregulated in patients with AH (n = 5) in comparison to normal controls (n = 7). Intricate linkage analysis of the downstream signaling pathways might provide further insight in to the exact role and as well as ...
It is concluded that (a) early intervention programs must use aggressive outreach to locate and assist children of alcoholics, (b) the entire family can benefit from treatment when one or both parents are alcoholic, and (c) existing services need to be expanded. (PsycINFO Database Record (c...
Comparison of Ethanolic and Hydro Alcoholic Leaf Extract of Madhuca indica in Treatment of Hepatotoxicity 来自 ResearchGate 喜欢 0 阅读量: 12 作者: Patel, Pushpendra K.,Sahu, Jyoti,Prajapati, Narendra K.,Dubey, B. K. 摘要: Synthetic medicine had occupied a large portion in today therapy, they...
It also hinders patient recruitment into clinical trials and their further development for treatment response monitoring. From a public health point of view, the lack of approved biomarker panels for diagnostic purposes is, thus, a major barrier to access to care and drug development9. Although ...
59,60 Thus, the mean weight loss difference observed in this review approximates that which we might expect if patients were offered treatment in 1 of the weight loss programs typically available in routine clinical care. Accordingly, we would expect to see similar improvements in liver biomarkers...
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52(1):79-104. doi:10.1002/hep.23623 PubMedGoogle ScholarCrossref 9. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic ...